Search results for "Pharmaceutical Research"

Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC

Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC

The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple antihypertensive drug—were published on...
U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market analysts suggest that the inclusion...
Why ‘Elegant Dining’ Might Be the Secret to Appetite Control

Why ‘Elegant Dining’ Might Be the Secret to Appetite Control

If you typically rush through a sandwich at your desk or eat in a chaotic environment, you might be missing out on a...
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?

Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?

These days, the pharmaceutical industry is focused on the topic of 'drug price reduction.
SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine

SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine

SK Bioscience is accelerating the development of the next-generation Ebola vaccine with funding support from the...
Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?

Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?

Yuhan Corporation recently announced plans to establish a specialized subsidiary for 'Research and Business Development...
NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years

NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years

Semiconductor company NVIDIA is partnering with global pharmaceutical company Eli Lilly to establish an artificial...
Ligakem Bio Receives ADC Platform Technology Fees from Ono Pharmaceutical

Ligakem Bio Receives ADC Platform Technology Fees from Ono Pharmaceutical

Ligakem Bioscience announced on the 8th that it is set to receive milestone payments related to the development...
Next-Generation Precision Medicine for Cancer Treatment... Amgen Acquires UK Biotech for 1 Trillion Won

Next-Generation Precision Medicine for Cancer Treatment... Amgen Acquires UK Biotech for 1 Trillion Won

Global pharmaceutical company Amgen is acquiring a UK biotech for up to $840 million (approximately 1.